[Drug surveillance. Which methods? For which adverse effects? Application to teratogen monitoring].
D064420:Drug-Related Side Effects and Adverse Reactions; D005069:Evaluation Studies as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D013723:Teratogens
D013723:Teratogens
La surveillance des médicaments. Quelle méthodologie? Pour quels effets indésirables? Application à la tératovigilance.